Pharmaceutical giant GlaxoSmithKline: We conducted clinical trial program for ...
News | 06 December 2012
VANCOUVER - Pharmaceutical giant GlaxoSmithKline says it conducted its clinical trial program for the anti-depressant drug Paxil appropriately in marketing the medicine for use by women of childbearing age. The statement comes after a B.C. Supreme ...
Click on the link to read the full article at Vancouver Sun
(This link will open in a new window)
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
